Cash flow Idemitsu Kosan Co.,Ltd.

Equities

5019

JP3142500002

Oil & Gas Refining and Marketing

Market Closed - Japan Exchange Other stock markets 14:30:00 09/01/2026 HKT			5-day change	1st Jan Change
1,211.50 ^JPY	+1.98%		+2.41%	+2.41%

01-07	Japan Refiners See Little Scope for Venezuelan Crude	MT
12-25	Japan's Cosmo Oil restarts Sakai CDU after unplanned shutdown	RE

8785fd60e102201df.0G4uRKTRjpOYhoxRzlzYpM2gT5qF1zY890sCpy0lsDQ.hB1iG96Qw8PU0sMh-z-I7PnZYu3WvlwPhhhY12Vt2mPjKBod0L_66_n04w

Published financial data: IDEMITSU KOSAN CO.,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	4,557B	6,687B	9,456B	8,719B	9,190B
Total Revenues	4,557B	6,687B	9,456B	8,719B	9,190B
Cost of Goods Sold, Total	3,998B	5,803B	8,662B	7,872B	8,501B
Gross Profit	559B	884B	794B	847B	689B
Selling General & Admin Expenses, Total	419B	450B	458B	501B	527B
Other Operating Expenses	-	-	53.73B	-	-
Other Operating Expenses, Total	419B	450B	512B	501B	527B
Operating Income	140B	434B	282B	346B	162B
Interest Expense, Total	-11.98B	-11.21B	-15.29B	-20.25B	-16.73B
Interest And Investment Income	14.17B	13.37B	7.95B	20.26B	22.01B
Net Interest Expenses	2.19B	2.16B	-7.34B	12M	5.28B
Income (Loss) On Equity Invest.	-39.79B	15.03B	25.98B	16.72B	22.6B
Currency Exchange Gains (Loss)	-	2.84B	14.61B	17.02B	20.12B
Other Non Operating Income (Expenses)	5.91B	4.79B	5.83B	5.18B	4.58B
EBT, Excl. Unusual Items	108B	459B	322B	385B	215B
Gain (Loss) On Sale Of Investments	-6.13B	3.34B	-12.27B	461M	2.5B
Gain (Loss) On Sale Of Assets	11.96B	11.87B	69.12B	7.14B	4.2B
Asset Writedown	-45.14B	-81.58B	-30.65B	-17.46B	-37.51B
Other Unusual Items	-4.48B	-4.84B	540M	-48.63B	-25.6B
EBT, Incl. Unusual Items	64.58B	388B	348B	327B	158B
Income Tax Expense	29.34B	111B	97.49B	99.91B	56.35B
Earnings From Continuing Operations	35.24B	277B	251B	227B	102B
Net Income to Company	35.24B	277B	251B	227B	102B
Minority Interest	-319M	2.7B	2.87B	1.68B	2.04B
Net Income - (IS)	34.92B	279B	254B	229B	104B
Net Income to Common Incl Extra Items	34.92B	279B	254B	229B	104B
Net Income to Common Excl. Extra Items	34.92B	279B	254B	229B	104B
Per Share Items
Net EPS - Basic	23.49	188.03	170.67	161.32	77.83
Basic EPS - Continuing Operations	23.49	188.03	170.67	161.32	77.83
Basic Weighted Average Shares Outstanding	1.49B	1.49B	1.49B	1.42B	1.34B
Net EPS - Diluted	23.49	188.03	170.67	161.32	77.83
Diluted EPS - Continuing Operations	23.49	188.03	170.67	161.32	77.83
Diluted Weighted Average Shares Outstanding	1.49B	1.49B	1.49B	1.42B	1.34B
Normalized Basic EPS	45.36	194.92	137.15	171.16	101.93
Normalized Diluted EPS	45.36	194.92	137.15	171.16	101.93
Dividend Per Share	24	24	24	32	36
Payout Ratio	119.41	12.79	19.96	17.6	44.34
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	248B	549B	396B	455B	267B
EBITA	150B	444B	292B	356B	172B
EBIT	140B	434B	282B	346B	162B
Effective Tax Rate - (Ratio)	45.44	28.67	27.99	30.58	35.58
Normalized Net Income	67.41B	290B	204B	242B	136B
Non-Cash Pension Expense	-323M	-3.59B	-3.32B	-2.88B	-4.73B
Supplemental Operating Expense Items
Selling and Marketing Expenses	96.39B	103B	108B	102B	112B
Research And Development Expense From Footnotes	20.47B	26.02B	23.64B	28.82B	33.92B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	131B	140B	105B	139B	166B
Total Cash And Short Term Investments	131B	140B	105B	139B	166B
Accounts Receivable, Total	601B	869B	841B	912B	814B
Other Receivables	-	243B	319B	308B	299B
Total Receivables	601B	1,112B	1,161B	1,221B	1,112B
Inventory	695B	1,060B	1,309B	1,378B	1,267B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	239B	55.28B	158B	179B	105B
Total Current Assets	1,666B	2,368B	2,732B	2,917B	2,650B
Net Property Plant And Equipment	1,522B	1,438B	1,390B	1,363B	1,374B
Long-term Investments	389B	464B	414B	403B	425B
Goodwill	159B	150B	140B	131B	124B
Other Intangibles, Total	160B	159B	150B	141B	130B
Loans Receivable Long-Term	37.72B	12.3B	23.94B	43.52B	56.49B
Deferred Tax Assets Long-Term	21.02B	10.6B	15.42B	14.41B	15.95B
Other Long-Term Assets, Total	2M	2M	2M	-	2M
Total Assets	3,954B	4,601B	4,865B	5,012B	4,776B
Liabilities
Accounts Payable, Total	531B	841B	697B	794B	824B
Accrued Expenses, Total	11.39B	13.94B	17.12B	16.68B	16.71B
Short-term Borrowings	522B	606B	789B	669B	646B
Current Portion of Long-Term Debt	20B	10B	-	10B	30B
Current Income Taxes Payable	425B	431B	458B	537B	436B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	112B	160B	203B	166B	144B
Total Current Liabilities	1,621B	2,061B	2,164B	2,192B	2,097B
Long-Term Debt	737B	721B	669B	619B	520B
Pension & Other Post Retirement Benefits	49.23B	71.65B	60.35B	51.79B	49.06B
Deferred Tax Liability Non Current	94.64B	119B	122B	124B	146B
Other Non Current Liabilities	237B	192B	221B	212B	225B
Total Liabilities	2,739B	3,165B	3,236B	3,200B	3,038B
Common Stock, Total	168B	168B	168B	168B	168B
Additional Paid In Capital	462B	461B	452B	390B	355B
Retained Earnings	401B	645B	849B	1,038B	1,111B
Treasury Stock	-2.01B	-1.88B	-14.79B	-11.01B	-140B
Comprehensive Income and Other	122B	140B	160B	214B	226B
Total Common Equity	1,151B	1,412B	1,615B	1,800B	1,720B
Minority Interest	64.21B	24.41B	14.78B	12.64B	17.33B
Total Equity	1,215B	1,437B	1,629B	1,813B	1,738B
Total Liabilities And Equity	3,954B	4,601B	4,865B	5,012B	4,776B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.49B	1.49B	1.47B	1.38B	1.22B
ECS Total Common Shares Outstanding	1.49B	1.49B	1.47B	1.38B	1.22B
Book Value / Share	774.34	949.94	1.1K	1.31K	1.4K
Tangible Book Value	832B	1,103B	1,324B	1,528B	1,466B
Tangible Book Value Per Share	559.55	742.32	903.94	1.11K	1.2K
Total Debt	1,280B	1,337B	1,458B	1,298B	1,196B
Net Debt	1,148B	1,197B	1,353B	1,159B	1,031B
Debt Equivalent of Unfunded Proj. Benefit Obligation	47.05B	28.28B	16.94B	-10.11B	-26.12B
Minority Interest, Total (Incl. Fin. Div)	64.21B	24.41B	14.78B	12.64B	17.33B
Equity Method Investments, Total	-	-	-	-	-
Inventories - Raw Materials, Total	293B	525B	569B	630B	516B
Inventories - Work In Process, Total	29.18B	1.19B	1.89B	1.34B	1.8B
Inventories - Finished Goods, Total	372B	534B	738B	746B	749B
Inventories - Others	1M	-	1M	-	1M
Full Time Employees	14.04K	14.21K	14.36K	13.99K	13.81K
Accumulated Allowance for Doubtful Accounts (Supple)	1.52B	1.03B	733M	6.6B	3.63B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	64.58B	388B	348B	327B	158B
Depreciation & Amortization - CF	98.16B	105B	104B	99.16B	95.66B
Amortization of Goodwill and Intangible Assets - (CF)	9.63B	9.51B	9.46B	9.4B	9.42B
Depreciation & Amortization, Total	108B	114B	114B	109B	105B
(Gain) Loss From Sale Of Asset	8.2B	4.04B	-43.3B	3.48B	23.02B
(Gain) Loss on Sale of Investments - (CF)	6.19B	209M	122M	-439M	-2.5B
(Income) Loss On Equity Investments - (CF)	39.79B	-15.03B	-25.98B	-16.72B	-22.6B
Other Operating Activities, Total	-5.75B	-27.14B	-66.9B	-109B	-87.81B
Change In Accounts Receivable	-19.8B	-250B	61.36B	-60.38B	148B
Change In Inventories	-82.78B	-354B	-99.61B	-58.98B	134B
Change In Accounts Payable	123B	274B	-200B	181B	-93.45B
Change in Other Net Operating Assets	-70.78B	12.76B	-121B	3.54B	114B
Cash from Operations	170B	146B	-32.84B	377B	477B
Capital Expenditure	-121B	-94.74B	-85.57B	-70.86B	-86.55B
Sale of Property, Plant, and Equipment	27.67B	44.36B	114B	13.86B	27.15B
Cash Acquisitions	-5.09B	-2.18B	555M	-	-13.6B
Divestitures	1.06B	1.08B	-	-	-
Sale (Purchase) of Intangible assets	-11.76B	-12.71B	-4.91B	-6.26B	-8.67B
Investment in Marketable and Equity Securities, Total	701M	-3.97B	28.75B	-7.5B	-29.44B
Net (Increase) Decrease in Loans Originated / Sold - Investing	3.07B	-2.04B	-16.22B	-23.12B	-2.77B
Other Investing Activities, Total	-4.44B	-41.42B	33.37B	28.07B	-4.62B
Cash from Investing	-110B	-112B	70.08B	-65.8B	-119B
Short Term Debt Issued, Total	76.11B	49B	74.89B	-	11.2B
Long-Term Debt Issued, Total	161B	68.52B	33.74B	48.28B	21.47B
Total Debt Issued	237B	118B	109B	48.28B	32.67B
Short Term Debt Repaid, Total	-128B	-7B	-	-100B	-59.12B
Long-Term Debt Repaid, Total	-124B	-77.67B	-112B	-124B	-104B
Total Debt Repaid	-252B	-84.67B	-112B	-224B	-163B
Issuance of Common Stock	59M	158M	319M	113M	136M
Repurchase of Common Stock	-25M	-33M	-13.09B	-57.36B	-165B
Common Dividends Paid	-41.7B	-35.74B	-50.63B	-40.22B	-46.14B
Common & Preferred Stock Dividends Paid	-41.7B	-35.74B	-50.63B	-40.22B	-46.14B
Other Financing Activities, Total	696M	-27.24B	-23.28B	-6.96B	-2.01B
Cash from Financing	-56.23B	-30B	-90.42B	-281B	-343B
Foreign Exchange Rate Adjustments	-3.23B	3.13B	17.23B	2.74B	1.84B
Miscellaneous Cash Flow Adjustments	462M	466M	1M	-	10.73B
Net Change in Cash	1.62B	8.07B	-35.95B	33.82B	27.35B
Supplemental Items
Cash Interest Paid	11.81B	11.35B	15.11B	20.36B	17.49B
Cash Income Tax Paid (Refund)	7.62B	36.7B	74.8B	115B	94.19B
Levered Free Cash Flow	25B	-56.02B	-279B	222B	302B
Unlevered Free Cash Flow	32.48B	-49.02B	-269B	235B	312B
Change In Net Working Capital	30.02B	327B	469B	12.83B	-201B
Net Debt Issued / Repaid	-15.26B	32.85B	-3.74B	-176B	-130B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.23	6.35	3.73	4.38	2.07
Return on Total Capital	3.5	10.31	6.02	6.98	3.35
Return On Equity %	2.92	20.88	16.36	13.18	5.75
Return on Common Equity	3.04	21.81	16.76	13.39	5.91
Margin Analysis
Gross Profit Margin %	12.27	13.22	8.4	9.72	7.5
SG&A Margin	9.19	6.73	4.84	5.74	5.74
EBITDA Margin %	5.44	8.21	4.19	5.22	2.91
EBITA Margin %	3.29	6.64	3.09	4.08	1.87
EBIT Margin %	3.07	6.5	2.99	3.97	1.76
Income From Continuing Operations Margin %	0.77	4.14	2.65	2.6	1.11
Net Income Margin %	0.77	4.18	2.68	2.62	1.13
Net Avail. For Common Margin %	0.77	4.18	2.68	2.62	1.13
Normalized Net Income Margin	1.48	4.33	2.16	2.78	1.48
Levered Free Cash Flow Margin	0.55	-0.84	-2.95	2.55	3.29
Unlevered Free Cash Flow Margin	0.71	-0.73	-2.84	2.7	3.4
Asset Turnover
Asset Turnover	1.16	1.56	2	1.77	1.88
Fixed Assets Turnover	3.04	4.52	6.69	6.34	6.72
Receivables Turnover (Average Receivables)	7.64	9.09	11.06	9.95	10.65
Inventory Turnover (Average Inventory)	6.07	6.61	7.31	5.86	6.43
Short Term Liquidity
Current Ratio	1.03	1.15	1.26	1.33	1.26
Quick Ratio	0.45	0.61	0.58	0.62	0.61
Operating Cash Flow to Current Liabilities	0.11	0.07	-0.02	0.17	0.23
Days Sales Outstanding (Average Receivables)	47.79	40.14	33.01	36.8	34.28
Days Outstanding Inventory (Average Inventory)	60.14	55.19	49.91	62.45	56.78
Average Days Payable Outstanding	45.13	40.58	31.5	34.36	35.2
Cash Conversion Cycle (Average Days)	62.79	54.75	51.41	64.89	55.86
Long Term Solvency
Total Debt/Equity	105.32	93.06	89.48	71.64	68.85
Total Debt / Total Capital	51.3	48.2	47.22	41.74	40.78
LT Debt/Equity	60.69	50.17	41.07	34.15	29.92
Long-Term Debt / Total Capital	29.56	25.99	21.68	19.9	17.72
Total Liabilities / Total Assets	69.27	68.78	66.51	63.84	63.61
EBIT / Interest Expense	11.69	38.77	18.47	17.1	9.69
EBITDA / Interest Expense	20.69	48.96	25.92	22.46	15.97
(EBITDA - Capex) / Interest Expense	10.58	40.51	20.33	18.96	10.8
Total Debt / EBITDA	5.16	2.44	3.68	2.85	4.48
Net Debt / EBITDA	4.63	2.18	3.41	2.55	3.86
Total Debt / (EBITDA - Capex)	10.09	2.94	4.69	3.38	6.62
Net Debt / (EBITDA - Capex)	9.06	2.64	4.35	3.02	5.7
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-24.63	46.75	41.42	-7.79	5.4
Gross Profit, 1 Yr. Growth %	35.29	58.16	-10.2	6.69	-18.62
EBITDA, 1 Yr. Growth %	146	121.4	-27.77	14.77	-41.25
EBITA, 1 Yr. Growth %	2.47K	196.58	-34.25	21.86	-51.76
EBIT, 1 Yr. Growth %	-3.73K	210.18	-34.99	22.61	-53.17
Earnings From Cont. Operations, 1 Yr. Growth %	-269.53	685.5	-9.4	-9.54	-55.03
Net Income, 1 Yr. Growth %	-252.26	700.4	-9.25	-9.91	-54.47
Normalized Net Income, 1 Yr. Growth %	-719.42	329.8	-29.65	18.95	-43.8
Diluted EPS Before Extra, 1 Yr. Growth %	-253.94	700.34	-9.23	-5.48	-51.75
Accounts Receivable, 1 Yr. Growth %	1.55	44.63	-3.27	8.48	-10.82
Inventory, 1 Yr. Growth %	11.5	52.65	23.43	5.3	-8.05
Net Property, Plant and Equip., 1 Yr. Growth %	2.96	-5.53	-3.32	-1.97	0.84
Total Assets, 1 Yr. Growth %	1.74	16.35	5.74	3.02	-4.72
Tangible Book Value, 1 Yr. Growth %	1.68	32.68	20.01	15.37	-4.06
Common Equity, 1 Yr. Growth %	0.08	22.69	14.34	11.48	-4.42
Cash From Operations, 1 Yr. Growth %	-621.11	-14.29	-122.48	-1.25K	26.33
Capital Expenditures, 1 Yr. Growth %	2.04	-21.74	-9.68	-17.19	22.14
Levered Free Cash Flow, 1 Yr. Growth %	-116.14	-324.12	397.3	-179.83	35.78
Unlevered Free Cash Flow, 1 Yr. Growth %	-122.15	-250.89	448.87	-187.37	32.92
Dividend Per Share, 1 Yr. Growth %	-25	0	0	33.33	12.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.47	5.17	44.06	14.19	-1.42
Gross Profit, 2 Yr. CAGR %	7.06	46.28	19.18	-2.12	-6.82
EBITDA, 2 Yr. CAGR %	1.2	133.37	26.46	-8.95	-17.88
EBITA, 2 Yr. CAGR %	-8.91	773.77	39.64	-10.49	-23.33
EBIT, 2 Yr. CAGR %	-11.62	960.91	42	-10.72	-24.22
Earnings From Cont. Operations, 2 Yr. CAGR %	-36.28	264.92	166.77	-9.47	-36.22
Net Income, 2 Yr. CAGR %	-34.52	249.09	169.51	-9.58	-35.95
Normalized Net Income, 2 Yr. CAGR %	-18.05	415.97	73.88	-8.52	-18.23
Diluted EPS Before Extra, 2 Yr. CAGR %	-45.92	251.01	169.53	-7.37	-32.47
Accounts Receivable, 2 Yr. CAGR %	15.3	21.19	18.28	2.44	-1.64
Inventory, 2 Yr. CAGR %	8.81	30.46	37.26	14	-1.6
Net Property, Plant and Equip., 2 Yr. CAGR %	23.86	-1.37	-4.43	-2.65	-0.58
Total Assets, 2 Yr. CAGR %	16.97	8.8	10.92	4.37	-0.93
Tangible Book Value, 2 Yr. CAGR %	0.87	16.15	26.19	17.67	5.21
Common Equity, 2 Yr. CAGR %	16.91	10.81	18.44	12.9	3.23
Cash From Operations, 2 Yr. CAGR %	6.24	111.34	-56.11	60.71	280.99
Capital Expenditures, 2 Yr. CAGR %	26	-10.64	-15.93	-13.52	0.57
Levered Free Cash Flow, 2 Yr. CAGR %	-35.12	-39.85	233.85	99.25	4.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	-29.19	-42.19	187.78	118.99	7.77
Dividend Per Share, 2 Yr. CAGR %	9.54	-13.4	0	15.47	22.47
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.89	14.75	16.08	24.15	11.18
Gross Profit, 3 Yr. CAGR %	4.22	21.94	24.33	14.86	-7.96
EBITDA, 3 Yr. CAGR %	-2.84	31.37	57.86	22.43	-21.32
EBITA, 3 Yr. CAGR %	-9.56	35.01	268.89	33.44	-27.16
EBIT, 3 Yr. CAGR %	-11.39	34.31	318.26	35.22	-28
Earnings From Cont. Operations, 3 Yr. CAGR %	-40.44	47.2	129.35	86.02	-28.3
Net Income, 3 Yr. CAGR %	-40.08	50.83	122.8	87.05	-28.06
Normalized Net Income, 3 Yr. CAGR %	-21.04	42.39	165.56	53.21	-22.23
Diluted EPS Before Extra, 3 Yr. CAGR %	-48.2	32.78	123.63	90.07	-25.47
Accounts Receivable, 3 Yr. CAGR %	7.36	24.35	12.42	14.92	-2.18
Inventory, 3 Yr. CAGR %	9.04	21.81	28.07	25.65	6.12
Net Property, Plant and Equip., 3 Yr. CAGR %	14.77	13.17	-2.03	-3.62	-1.5
Total Assets, 3 Yr. CAGR %	10.63	16.76	7.77	8.22	1.25
Tangible Book Value, 3 Yr. CAGR %	-0.64	10.52	17.43	22.47	9.93
Common Equity, 3 Yr. CAGR %	9.83	18.8	11.97	16.07	6.8
Cash From Operations, 3 Yr. CAGR %	7.62	-1.09	0.13	30.33	48.32
Capital Expenditures, 3 Yr. CAGR %	27.74	7.51	-10.32	-16.35	-2.97
Levered Free Cash Flow, 3 Yr. CAGR %	-18.81	-1.92	21.63	107.22	75.34
Unlevered Free Cash Flow, 3 Yr. CAGR %	-14.92	-8.88	22.41	93.42	85.41
Dividend Per Share, 3 Yr. CAGR %	14.47	6.27	-9.14	10.06	14.47
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5	15.95	20.44	14.53	8.74
Gross Profit, 5 Yr. CAGR %	16.45	16.08	9.96	11.68	10.78
EBITDA, 5 Yr. CAGR %	31.99	21.58	7.96	13.45	21.54
EBITA, 5 Yr. CAGR %	52.06	26.63	7.61	14.54	96.79
EBIT, 5 Yr. CAGR %	48.12	26.29	7.01	14.07	111.2
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.63	25.05	8.5	21.19	37.46
Net Income, 5 Yr. CAGR %	-0.6	25.96	9.34	22.92	35.32
Normalized Net Income, 5 Yr. CAGR %	38.34	27.76	8.28	19.29	65.78
Diluted EPS Before Extra, 5 Yr. CAGR %	-12.19	11.27	0.19	14.96	38.52
Accounts Receivable, 5 Yr. CAGR %	18.48	21.77	11.6	15.07	6.57
Inventory, 5 Yr. CAGR %	13.87	19.73	19.56	18.63	15.26
Net Property, Plant and Equip., 5 Yr. CAGR %	7.37	7.06	6.66	6.55	-1.45
Total Assets, 5 Yr. CAGR %	10.48	11.74	10.75	11.64	4.2
Tangible Book Value, 5 Yr. CAGR %	11.76	14.46	9.33	13.33	12.38
Common Equity, 5 Yr. CAGR %	18.11	19.32	13.2	16.41	8.39
Cash From Operations, 5 Yr. CAGR %	-4.66	22.24	-24.82	20.1	70.89
Capital Expenditures, 5 Yr. CAGR %	15.02	17.98	8.06	-1.46	-6.11
Levered Free Cash Flow, 5 Yr. CAGR %	-30.57	56.3	42.93	30.23	14.29
Unlevered Free Cash Flow, 5 Yr. CAGR %	-27.49	32.97	38.53	29.4	16.33
Dividend Per Share, 5 Yr. CAGR %	19.14	19.14	8.45	9.86	2.38